Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




McCormick Scientific Takes Over Paraplast

By Labmedica staff writers
Posted on 29 Aug 2005
A new company called McCormick Scientific (St.Louis, MO, USA), formed earlier this year, has taken over Paraplast Embedding Media from Tyco Healthcare (Mansfield, MA, USA). More...


Paraplast Embedding Media is the leading producer of medical-grade paraffin used around the world. The company's new owner, McCormick Scientific, is developing and manufacturing laboratory supplies and medical instruments used in diagnosing cancer. Many of the tests used to diagnose, identify, and differentiate various forms of cancer require tissue samples. After these are taken from a patient, the samples are usually frozen, placed in a small cassette, and embedded with special, medical-grade paraffin. Later, the processed tissue is cut into very thin ribbons for analysis. The majority of the paraffin used around the world for this task is produced by Paraplast.

"Paraplast, in other words, provides us with an entry point into labs all over the world,” explained Douglas L. Martin, CEO and president of McCormick Scientific. "We intend not only to grow this business but to use this channel to launch a new line of laboratory supplies and disposable medical products, including the cassettes that hold the tissue and the microtome blades used to cut it.”

Mr. Martin notes that today's biopsy specimens are smaller, often only 1-2 mm in size, and are collected using minimally invasive, image-guided techniques. "Our mission is to provide tools that improve lab efficiencies and increase the accuracy of diagnostics.”

Dr. James McCormick, for whom the new company is named, is known in the industry as the founder of many histo-technology tools and processes. He first conceived and invented many of the tissue embedding and processing techniques and histology equipment that transformed the industry in the 1960s.





Related Links:
McCormick Scientific
Tyco Healthcare

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.